Try our beta test site

Incentive Programs for Female Substance Abusers Who Smoke - 3

This study has been completed.
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00064922
First received: July 15, 2003
Last updated: January 11, 2017
Last verified: May 2008
  Purpose
The purpose of this study is to examine the effects of incentive programs for the treatment of nicotine dependence in women who have problems with substance dependence.

Condition Intervention Phase
Tobacco Use Disorder
Behavioral: Behavior Therapy
Phase 2
Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Incentive Programs for Female Substance Abusers Who Smoke

Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment: 90
Study Start Date: January 2002
Study Completion Date: April 2006
Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)
Detailed Description:
This study will determine the influence of voucher-based CM on reducing smoking (and other drug) use during pregnancy or in post-partum women with children under 1 year of age living with them, or in non-pregnant females who smoke. We are targeting smoking cessation since cigarette use is so prevalent in our service. We will compare a control group to two different voucher-based contingent-reinforcement procedures: one that targets smoking abstinence alone vs. one that offers additional incentives for negative BAL and urinalysis results.
  Eligibility

Ages Eligible for Study:   15 Years to 99 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Pregnant and or post-partum with at least one child under 1 year old living with them, or non-pregnant, non-post-partum females or previous participant in this study protocol
  • Nicotine Dependent as confirmed by DSM-IV checklist
  • Current cigarette smoker
  • Breath CO reading of at least 8 ppm at the time of the initial study screening
  • Current client with the Shields for Families (Shields) treatment programs

Exclusion Criteria:

  • Non-smoker
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00064922

Locations
United States, California
Shields for Families, Inc.
Los Angeles, California, United States, 90061
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Leslie Amass, Ph.D. Los Angeles Treatment Research Center
  More Information

ClinicalTrials.gov Identifier: NCT00064922     History of Changes
Other Study ID Numbers: NIDA-13638-3  R01-13638-3 
Study First Received: July 15, 2003
Last Updated: January 11, 2017

Keywords provided by National Institute on Drug Abuse (NIDA):
nicotine dependence

Additional relevant MeSH terms:
Tobacco Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on February 20, 2017